ArticleOncoTargets and therapy2018

Alternative treatment strategies to sorafenib in patients with advanced hepatocellular carcinoma: a meta-analysis of randomized Phase III trials.

Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.